Psychedelic drug contender stocks drop after FDA rejects MDMA treatment MarketWatchsource Post navigation First psychedelic-assisted PTSD therapy delayed by FDA CRL to Lykos – BioWorld OnlineOptimi Health and Psyence Biomedical Sign Non-Binding – GlobeNewswire
